scholarly journals Single lung transplantation for end stage emphysema.

Thorax ◽  
1995 ◽  
Vol 50 (5) ◽  
pp. 562-564 ◽  
Author(s):  
N P Briffa ◽  
C Dennis ◽  
T Higenbottam ◽  
S A Nashef ◽  
S R Large ◽  
...  
Author(s):  
Kajetan Kiełbowski ◽  
Nikola Ruszel ◽  
Seweryn Skrzyniarz ◽  
Maria Piotrowska ◽  
Tomasz Grodzki ◽  
...  

Introduction: Single lung transplantation (SLuTx) is a challenging operation for patients with end-stage chronic pulmonary diseases. After surgery, native lung hyperinflation (NLH) and a mediastinal shift may develop, which changes the anatomical position of the lungs and heart and may lead to graft compression. Aim: We present a case report of a patient who developed NLH after SLuTx. We discuss the treatment methods and compare the outcomes with other case reports and analysis from world literature. Case study: A 56-year-old female patient was diagnosed with end-stage chronic obstructive pulmonary disease (FEV1 < 30%) and qualified for right SLuTx. After the procedure, spirometry revealed gradual loss in FEV1. Radiological images confirmed NLH and compression of the graft. Therefore, a native lung pneumonectomy was performed with positive outcomes. Results and discussion: NLH is a known complication of SLuTx. Typically, lung volume reduction surgery is performed to reduce the compression and a pneumonectomy is a rare treatment, even in centres with extensive experience with SLuTx. Conclusions: Despite SLuTx being a common approach in many pulmonary diseases, NLH should be always taken into consideration. Hyperinflation could cause a dangerous loss of respiratory efficiency and require invasive surgeries for lung transplant recipients.


Heart ◽  
1991 ◽  
Vol 66 (6) ◽  
pp. 431-434 ◽  
Author(s):  
J C Doig ◽  
P A Corris ◽  
C J Hilton ◽  
J H Dark ◽  
R S Bexton

1989 ◽  
Vol 98 (3) ◽  
pp. 350-354 ◽  
Author(s):  
C.G.A. McGregor ◽  
J.H. Dark ◽  
C.J. Hilton ◽  
R. Freeman ◽  
I.D. Conacher ◽  
...  

1996 ◽  
Vol 9 (10) ◽  
pp. 2007-2011 ◽  
Author(s):  
Ø. Bjørtuft ◽  
S. Simonsen ◽  
O.R. Geiran ◽  
J.G. Fjeld ◽  
E. Skovlund ◽  
...  

Lung ◽  
2021 ◽  
Vol 199 (1) ◽  
pp. 29-35
Author(s):  
Douglas Zaione Nascimento ◽  
Guilherme Watte ◽  
Felipe Soares Torres ◽  
Sadi Marcelo Schio ◽  
Leticia Sanchez ◽  
...  

2021 ◽  
Vol 30 (3) ◽  
pp. 178-183
Author(s):  
Kate McEwen ◽  
Lyndell Brodie

Lung transplantation is a well-established treatment for a variety of end-stage pulmonary diseases. However, the journey of a lung transplant recipient is complex and multifaceted. Silicosis is a rare indication for lung transplantation, but no other treatment is yet available for this disease in its end stages. This Australian case study presents a 52-year-old man with silicosis who received bilateral lung transplantation. The patient was frequently noncompliant with noninvasive ventilation therapy and experienced the complication of type 2 respiratory failure. Patient education and support provided, particularly around medication management following transplantation surgery, are discussed here. The patient's social situation and its implications for both him and his family are also considered.


Sign in / Sign up

Export Citation Format

Share Document